Exact Sciences gains $3B market opportunity as FDA approves Cologuard for 45 and older

Since being FDA approved in 2014, Cologuard has been available to individuals age 50 and older who are at average risk for colorectal cancer, but the population of those 45 to 49 sharply expands the market for Cologuard to 19 million people in the U.S.